fruzaqla

HUTCHMED to Receive Milestone Payment from Takeda following FirstEuropeanReimbursement for FRUZAQLA (fruquintinib)HUTCHMED to Receive Milestone Payment from Takeda following FirstEuropeanReimbursement for FRUZAQLA (fruquintinib)

HUTCHMED to Receive Milestone Payment from Takeda following FirstEuropeanReimbursement for FRUZAQLA (fruquintinib)

— US$10 million milestone payment to HUTCHMED follows first national reimbursement in Europe — — Follows June 2024 European approval of…

3 months ago